Physician profile
Faustine Quigley
NPI 1306670385
$656.89
in general payments reported to CMS, 2019-2025
19 companies · $520 in 2025
The $520 reported for 2025 was more than what 75% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $137 · 2025: $520.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $657.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $656.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $85.76 | 2024 | Inspire |
| Abbvie INC. | $76.48 | 2024-2025 | |
| Exact Sciences Corporation | $52.24 | 2024-2025 | Cologuard Collection Kit |
| Edwards Lifesciences Corporation | $42.86 | 2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Xeris Pharmaceuticals, INC. | $40.10 | 2025 | Gvoke Hypopen, Keveyis |
| Boston Scientific Corporation | $35.56 | 2025 | Wavewriter Alpha Prime 16 |
| Novo Nordisk INC | $32.38 | 2025 | Wegovy, Ozempic, Rybelsus |
| Amgen INC. | $31.66 | 2025 | Repatha, Otezla |
| Grifols USA, LLC | $29.52 | 2025 | Prolastin-C Liquid |
| Currax Pharmaceuticals LLC | $27.38 | 2025 | Contrave |
| Abiomed | $27.00 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $25.90 | 2025 | Trintellix |
| Astrazeneca Pharmaceuticals LP | $24.78 | 2025 | Airsupra |
| Ibsa Pharma INC. | $22.35 | 2025 | Flector, Licart, Tirosint |
| Sanofi-Aventis U.S. LLC | $22.32 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $21.58 | 2025 | |
| Medtronic, INC. | $20.73 | 2025 | Symplicity G3 |
| Genzyme Corporation | $19.63 | 2025 | |
| Pfizer INC. | $18.66 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Faustine Quigley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.